These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6350090)

  • 41. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
    Härtel G
    Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oral propafenone in the long-term treatment of chronic ventricular arrhythmia].
    Vázquez García A; Marcos Sánchez F; Górgolas Hernández-Mora P; Durán Pérez-Navarro A
    Rev Clin Esp; 1986 Jun; 179(2):101. PubMed ID: 3738054
    [No Abstract]   [Full Text] [Related]  

  • 43. [Oral propafenone in chronic ventricular arrhythmias. Prospective evaluation with the Holter monitor].
    Sánchez Domínguez J; Roldán I; Navarro A; Villa JG; Urbina FJ; Barciela R; Barras C
    Rev Clin Esp; 1985 Nov; 177(8):372-5. PubMed ID: 3836459
    [No Abstract]   [Full Text] [Related]  

  • 44. [The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy].
    Palazzuoli V; Mondillo S; Faglia S; D'Aprile N; Camporeale A; Gennari C
    Clin Ter; 1993 Feb; 142(2):155-9. PubMed ID: 7682488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of chronic ventricular arrhythmias with the new class Ic anti-arrhythmia agent diprafenon--results of long-term therapy].
    Heuer H; Gülker H; Hasfeld M; Frenking B; Behrenbeck T
    Z Kardiol; 1987 Jul; 76(7):415-20. PubMed ID: 3673163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.
    Hodges M; Salerno D; Granrud G
    Am J Cardiol; 1984 Nov; 54(9):45D-50D. PubMed ID: 6388303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of chronic ventricular extrasystole with propafenone (Rhythmonorm)].
    Dimitrov D
    Vutr Boles; 1984; 23(4):65-9. PubMed ID: 6209861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The use of propafenon in the acute and chronic treatment of supraventricular and ventricular arrhythmias].
    Menozzi C; Lolli G; Gheller G; Monducci I; Vergoni W; Cattabiani ML; Manenti E; Casali G
    Clin Ter; 1983 Apr; 105(2):125-33. PubMed ID: 6345053
    [No Abstract]   [Full Text] [Related]  

  • 50. A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes.
    Salerno DM; Granrud G; Sharkey P; Asinger R; Hodges M
    Am J Cardiol; 1984 Jan; 53(1):77-83. PubMed ID: 6362387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E; Vitali A; Cucchi GF
    Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
    [No Abstract]   [Full Text] [Related]  

  • 52. [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)].
    Weber H; Eigster G; Wesselhoeft H
    Monatsschr Kinderheilkd; 1981 Jul; 129(7):410-3. PubMed ID: 6167855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Holter analysis of ventricular arrhythmias and its treatment with propafenone].
    Peralta Heredia R
    Arch Inst Cardiol Mex; 1986; 56(3):225-30. PubMed ID: 2428317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
    Poggesi L; Scarti L; Ieri A; Lanzetta T; Grazzini M; Del Bene P; Masini G; Del Citerna F; Carnovali M; Masotti G
    Int J Clin Pharmacol Res; 1989; 9(4):269-75. PubMed ID: 2476406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
    Mondillo S; Faglia S; D'Aprile N; Mangiacotti L; Campolo MA; Agricola E; Palazzuoli V
    Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hemodynamic effects of propafenone in acute myocardial infarct].
    Finzi A; Ambrosini F; Pagnoni F; Massari FM; Valentini R; Lotto A
    G Ital Cardiol; 1984 May; 14(5):367-72. PubMed ID: 6468818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy and tolerance of propafenone in the treatment of cardiac rhythm disorders. Evaluation of a multicenter open trial on 3,687 patients].
    Clémenty J; Coste P; Metzinger M
    Ann Cardiol Angeiol (Paris); 1987 Apr; 36(4):207-12. PubMed ID: 3296928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N; Terry L; Murphy ML; Thompson CH; Doherty JE; Sakhaii M; Dinh H
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study of the electrophysiologic effects of propafenon in patients with cardiac pre-excitation].
    Disertori M; Vergara G; Inama G; Guarnerio M; Dal Forno P; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(11):1725-8. PubMed ID: 7349232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.